Figure 6.
Comparing time-to-first systemic treatment between patients with CD5+ vs CD5– MZL. NE, not estimable.

Comparing time-to-first systemic treatment between patients with CD5+ vs CD5– MZL. NE, not estimable.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal